Search research articles
Contact Us
Filters
Showing results (71-80 of 98) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02
Lester J Peters, Brian O'Sullivan, Jordi Giralt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 8, 2003
Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas
Azza A Khalil, Søren M Bentzen, Jacques Bernier, et al.
Radiation Oncology (London, England)
|
February 14, 2015
Impact of weight loss on survival after chemoradiation for locally advanced head and neck cancer: secondary results of a randomized phase III trial (SAKK 10/94)
Pirus Ghadjar, Stefanie Hayoz, Frank Zimmermann, et al.
Plos Pathogens
|
May 27, 2021
The RyfA small RNA regulates oxidative and osmotic stress responses and virulence in uropathogenic Escherichia coli
Hicham Bessaiah, Pravil Pokharel, Hamza Loucif, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 9, 2011
Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94)
Pirus Ghadjar, Mathew Simcock, Gabriela Studer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group
Danny Rischin, Lester J Peters, Brian O'Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 22, 2010
Gefitinib in combination with irradiation with or without cisplatin in patients with inoperable stage III non-small cell lung cancer: a phase I trial
Sacha Rothschild, Stephan E Bucher, Jacques Bernier, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
December 1, 2021
Intrauterine Administration of Activated Peripheral Blood Mononuclear Cells in Intrauterine Insemination: A Prospective Double-Blind Randomized Clinical Trial
Fabien Joao, Guillaume Ricaud, Julie Lamoureux, et al.
Head & Neck
|
September 15, 2005
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
Jacques Bernier, Jay S Cooper, T F Pajak, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 15, 2004
Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863
Fatma Ataman, Alfredo Zurlo, Xavier Artignan, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 98) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02
Lester J Peters, Brian O'Sullivan, Jordi Giralt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 8, 2003
Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas
Azza A Khalil, Søren M Bentzen, Jacques Bernier, et al.
Radiation Oncology (London, England)
|
February 14, 2015
Impact of weight loss on survival after chemoradiation for locally advanced head and neck cancer: secondary results of a randomized phase III trial (SAKK 10/94)
Pirus Ghadjar, Stefanie Hayoz, Frank Zimmermann, et al.
Plos Pathogens
|
May 27, 2021
The RyfA small RNA regulates oxidative and osmotic stress responses and virulence in uropathogenic Escherichia coli
Hicham Bessaiah, Pravil Pokharel, Hamza Loucif, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 9, 2011
Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94)
Pirus Ghadjar, Mathew Simcock, Gabriela Studer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group
Danny Rischin, Lester J Peters, Brian O'Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 22, 2010
Gefitinib in combination with irradiation with or without cisplatin in patients with inoperable stage III non-small cell lung cancer: a phase I trial
Sacha Rothschild, Stephan E Bucher, Jacques Bernier, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
December 1, 2021
Intrauterine Administration of Activated Peripheral Blood Mononuclear Cells in Intrauterine Insemination: A Prospective Double-Blind Randomized Clinical Trial
Fabien Joao, Guillaume Ricaud, Julie Lamoureux, et al.
Head & Neck
|
September 15, 2005
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
Jacques Bernier, Jay S Cooper, T F Pajak, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 15, 2004
Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863
Fatma Ataman, Alfredo Zurlo, Xavier Artignan, et al.
Page
of 10